Top official says US still assessing how to test nuclear weapons

U.S. Undersecretary Thomas DiNanno said Washington is still assessing how to implement President Trump’s October directive to resume nuclear-weapons testing, with no discussions underway about atmospheric tests but not ruling out a return to underground explosive tests (last underground test in 1992; last atmospheric in 1962). DiNanno provided no firm decisions on scope or timing and reiterated U.S. allegations that Russia and China have conducted underground explosive tests. For portfolios, the comments raise geopolitical and defense-sector risk and could be risk-off for energy and risk-sensitive assets until policy clarity emerges.

Analysis

A hawkish policy signal around the nuclear posture functions as a compact catalyst that re-rates a narrow set of defense suppliers and specialty manufacturers within days while leaving larger macro allocations to play out over months. Smaller contractors and component suppliers that directly service weapons programs can see revenue trajectories move by double-digit percentages on relatively modest incremental budgets (a multibillion-dollar program over 3 years is material for $1–5bn market‑cap names but immaterial for $100bn+ integrators). Markets tend to front-run appropriations; expect idiosyncratic earnings and backlog revisions from vendors ahead of formal budgetary votes.

Second-order supply-chain winners include precision machining, high‑explosive handling, and classified logistics firms — segments with high entry barriers and pricing power — rather than commodity uranium or civilian nuclear OEMs. Geopolitical risk premia transmitted through energy and freight markets remain the most likely channel to broaden the impact, creating a transitory inflation impulse that pressures rate-sensitive growth exposures over 1–6 months. Conversely, legal, technical or alliance pushback creates asymmetric downside for small-cap contractors that have already repriced on headline risk.

Key catalysts and reversals are political (appropriations, hearings) on a 1–6 month cadence and operational (tests or inspection outcomes) over years; litigation, treaty diplomacy, or a domestic funding impasse are rapid reversal triggers. Position sizing should assume high headline volatility and potential 20–40% drawdowns in small-cap defense contractors if Congress constrains spending or if confirmation hearings uncover program delays. Liquidity and option structures matter: prefer directional exposure via liquid calls or ETFs for timing risk, while using puts as cheap tail hedges against a short, sharp de‑escalation that would compress risk premia quickly.

Key Decisions for Investors

• Long BWXT (BWXT) — buy 12‑month term exposure via 1x stock or 1.5x notional in 12‑month OTM calls (approx 20% OTM). Size as 3–6% portfolio target exposure. R/R: if incremental program funding commits, expect 40–80% upside; stop‑loss at 30% drawdown from entry to limit idiosyncratic risk.
• Long Lockheed Martin (LMT) — accumulate 6–12 month position (stock or covered calls) as a core hedge to elevated geopolitical risk. Size 4–8% of equity sleeve. R/R: 12–25% upside if procurement visibility improves; downside limited relative to small-cap suppliers given diversification.
• ETF play — long iShares U.S. Aerospace & Defense ETF (ITA) via a 3–6 month call spread to capture near‑term repricing while capping premium outlay. Target 10–20% gain if defense budgets rebaseline; max loss is premium paid.
• Portfolio hedge — buy 3‑month ATM puts on QQQ sized to 2–3% of portfolio value to protect against a short, inflation‑driven equity drawdown. Expect to pay premium; this is insurance against a broad market selloff if geopolitical risk spills into energy and rates.